Clinical trials
Hospitalized Patients clinical trials
Below are recruiting hospitalized patients clinical trials, each written for real people, not researchers. We’re tracking 3,562 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03394417Recruiting
StrataXRT skin gel to prevent rash during head and neck radiation
This trial tests whether a medicated skin gel (StrataXRT) can better prevent painful skin rash (“acute dermatitis”) in people with head and neck cancer who receive chemotherapy and radiation at the same time. If you’re eligible, you may get the study skin product and help doctors find a safer, more comfortable way to protect the skin during treatment.
SingaporeAges 21–80 - NCT03535545RecruitingPhase 1
PET-MRI imaging test in lung cancer and lung disease
This Phase 1 study tests a radioactive imaging agent to help doctors see disease activity in the lungs using PET/MRI scans. It includes healthy volunteers and people with lung cancer, idiopathic pulmonary fibrosis, lung transplant–related lung problems, or certain medication-related lung inflammation.
Boston, MassachusettsAges 18–80 - NCT03649503Recruiting
Parkinsonian disorders registry in China
This study is a real-world registry that collects information from people living with Parkinsonian disorders in China. It may help researchers better understand how these conditions affect patients day to day.
Shanghai, Shanghai MunicipalityAges Any age - NCT03787589Recruiting
Exercise program for people on dialysis
This trial studies whether a structured exercise program (using Nordic walking poles) is safe and helpful for adults with end-stage kidney disease who are on dialysis. You may be eligible if you can do the exercise safely and are able to consent.
Ottawa, OntarioAges 18 years+ - NCT03869554Recruiting
Screening for Fabry disease in people with kidney biopsy results
This study tests a screening approach to find Fabry disease in adults whose kidney biopsy findings are unclear or suggest certain kidney patterns. If Fabry disease is missed, it can delay targeted treatment, so screening may help identify people who could benefit from earlier care.
AngersAges 18 years+ - NCT03993262RecruitingPhase 2
Bortezomib for severe autoimmune encephalitis after rituximab
This Phase 2 study tests whether bortezomib can improve outcomes and safety in adults with severe autoimmune encephalitis. It focuses on people whose condition is confirmed by brain-related autoantibodies and who have already received rituximab.
München, BavariaAges 18 years+ - NCT04330729Recruiting
Aspirin effect on blood clotting in kidney disease
This study checks how aspirin (also called salicylate) affects how platelets work, which helps blood clot. It involves people with advanced chronic kidney disease who are treated with Aranesp, and it may help guide safer care.
RoskildeAges 18–85 - NCT04487340Recruiting
Online database for people with acute stroke care
This study sets up an online database to track people who have had a stroke soon after it happens. The goal is to understand and improve how stroke care quality is evaluated.
Hangzhou, ZhejiangAges Any age - NCT04492345Recruiting
Back muscle training for posture problems in Parkinson’s
This trial tests a special way to strengthen the back muscles to improve posture problems in people with Parkinson’s (or similar conditions). It may help reduce postural deformities and improve movement comfort while your Parkinson’s treatment stays steady.
Le LamentinAges 18–85 - NCT04554277Recruiting
Blood test-guided care for people hospitalized with heart failure
This study checks whether using a specific blood test (called sST-2) to guide heart-failure treatment leads to better care and outcomes. It may help by tailoring treatment decisions based on your test results.
Montpellier, OccitanieAges 18 years+ - NCT04712305Recruiting
Urine test to predict kidney cancer response to immunotherapy
This study uses an at-home-style urine test (urine “omics,” meaning detailed lab information) to help predict how well immunotherapy may work for advanced kidney cancer. If you join, your urine results may help doctors tailor treatment choices and better understand who benefits most.
TaipeiAges 20 years+ - NCT04776759Recruiting
Study of first atrial fibrillation in young adults
This study records and follows people under 35 who have their first episode of an irregular heartbeat. It aims to better understand this condition early on and how it shows up in real life.
Caen, NormandyAges Up to 35 years - NCT05191485Recruiting
Helping lung cancer patients decide about genetic testing
This study tests a shared decision-making approach to help people with lung adenocarcinoma decide whether to get molecular (genetic) testing. It aims to improve understanding and support better choices about testing and possible targeted treatments.
Chengdu, SichuanAges 18 years+ - NCT05212454RecruitingPhase 3
Capecitabine added after surgery for high-risk ER-positive breast cancer
This Phase 3 study tests whether adding capecitabine (a chemotherapy pill) after breast cancer surgery can lower the chance the cancer comes back. It targets people with hormone-receptor–positive and HER2-negative breast cancer who are considered “high risk.”
Hanzhou, ZhejiangAges 18–70 - NCT05325424Recruiting
Laparoscopic spleen surgery for people with cirrhosis
This study looks at whether removing the spleen using keyhole surgery can improve “liver reserve function” in people with cirrhosis. It may be considered for patients who have an enlarged spleen and very low platelets, but it also has several safety exclusions.
Yangzhou, JiangsuAges 18 years+ - NCT05470335Recruiting
Nurse-led heart procedure setup for suspected heart artery disease
This study checks whether a nurse-led technique for placing a sheath (a small tube used during a heart test/procedure) works safely in people suspected of blocked heart arteries. If you qualify, your care team will guide the process and compare how it goes with standard approaches.
Roskilde, DanmarkAges 18 years+ - NCT05501080Recruiting
Testing a hormone treatment to improve heart changes in PA
This trial tests whether a treatment called SAAE can improve “ventricular remodeling,” meaning changes in the heart muscle, in people with primary aldosteronism (PA). It may help the heart work more efficiently by targeting the cause of high aldosterone levels.
NanchangAges 18–60 - NCT05516667Recruiting
Study of Alzheimer’s patients and their families
This study follows people with Alzheimer’s disease and family members over 2 years. It uses regular questionnaires and medical checkups to better understand needs and health changes for patients and caregivers.
France, MarseilleAges 18 years+ - NCT05518851Recruiting
Study of treatments and outcomes for primary skin lymphoma
This study looks at what treatments work for people with primary cutaneous lymphoma, and how patients do over time. It uses real patient information from participating hospitals to understand outcomes after diagnosis.
Beijing, Beijing MunicipalityAges Any age - NCT05540548Recruiting
Podiatry assessment for balance and pain in chronic back pain
This study looks at whether a foot and posture specialist can help measure how balance relates to the pain you feel in chronic low back pain. It may help doctors better understand what to focus on for pain that lasts for months.
ValenciennesAges 18 years+ - NCT05561361Recruiting
Test treatment for primary aldosteronism and blood vessel function
This trial studies whether a specific treatment (related to spironolactone/aldosterone support) can improve how well your blood vessels work in people with primary aldosteronism. It may help reduce blood pressure risk by improving blood vessel health.
NanchangAges 18–75 - NCT05667090Recruiting
High-dose vitamin D3 to ease chronic pain in dialysis patients
This study tests whether taking a very high dose of vitamin D3 can reduce moderate to severe chronic pain in people on hemodialysis. It may help by improving vitamin D-related pathways that could affect pain, but you must also meet specific health and testing requirements.
TaipeiAges 20 years+ - NCT05671666Recruiting
Testing urea processing in healthy people and urea cycle disorder
This study measures how your body breaks down protein-related waste and makes urea. It includes both healthy volunteers and people with urea cycle disorders, which may help researchers better understand the condition and improve testing.
Zurich, Canton of ZurichAges Any age - NCT05689385Recruiting
Online cardiac rehab after a heart attack you can do at home
This trial tests an eHealth (phone or internet-based) cardiac rehabilitation program for people after a heart attack, meant to help you recover with safer activity guidance. It may fit you if you’re not able to go to a rehab clinic in person.
TaipeiAges 20 years+
Hear when a new Hospitalized Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalized patients?
- Yes. Clin2 currently lists 3,562 recruiting hospitalized patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalized patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalized patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.